Directory › Lonza
Lonza — Houston
Houston, Texas, United States · CDMO
Site facts
- Company
- Lonza
- Name(s) in FDA data
- Lonza Houston, Inc
- FEI number(s)
- 3013629214 (present in FDA Data Dashboard records for this name and city)
- Location (as in FDA data)
- Houston, Texas, United States 77047
- Records matched
- 1 FDA inspection
- Most recent FDA inspection in dataset
- 10 Dec 2020 — NAI
Capabilities (from the company's website)
- Biologics drug substance
…r gene therapy applications. Learn... Learn more Exosomes Leverage our knowledge in 2D/3D cell culture and the latest exosome characterization technologies to define your complete path for exo…
- Cell & gene therapy
…Skip to main content Services provided at this site Offerings Cell and Gene Offerings Catalog Autologous Improve the success of your autologous cell therapy manufact…
- Formulation & process development
…ade, fully cGMP iPSC produced at highest quality, with a clear licensing path. Learn more Process Development Identify critical quality attributes while creating a robust, scalable and reproducible c…
Taken from the company's web page for this site. Source: https://www.lonza.com/about-us/our-locations/houston-tx-usa, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.
Regulatory timeline
Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.
-
10 Dec 2020FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Biologics. Project area(s): Vaccines and Allergenic Products.
Source: FDA Data Dashboard – Inspections (FEI 3013629214, inspection ID 1133868)
This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.